LCM
ALXN
Laurion Capital Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-11,200
| Closed | -$1.71M | – | 784 |
|
|
2021
Q1 | $1.71M | Buy |
11,200
+5,200
| +87% | +$795K | 0.01% | 245 |
|
|
2020
Q4 | $937K | Sell |
6,000
-12,090
| -67% | -$1.89M | 0.01% | 231 |
|
|
2020
Q3 | $2.07M | Buy |
+18,090
| New | +$2.07M | 0.02% | 152 |
|
|
2019
Q3 | – | Sell |
-17,929
| Closed | -$2.35M | – | 932 |
|
|
2019
Q2 | $2.35M | Buy |
+17,929
| New | +$2.35M | 0.02% | 105 |
|
|
2017
Q4 | – | Sell |
-22,698
| Closed | -$3.18M | – | 1458 |
|
|
2017
Q3 | $3.18M | Buy |
+22,698
| New | +$3.18M | 0.01% | 274 |
|
|
2017
Q2 | – | Sell |
-89,000
| Closed | -$10.8M | – | 1436 |
|
|
2017
Q1 | $10.8M | Buy |
+89,000
| New | +$10.8M | 0.08% | 70 |
|
|
2016
Q2 | – | Sell |
-6,300
| Closed | -$877K | – | 806 |
|
|
2016
Q1 | $877K | Buy |
+6,300
| New | +$877K | 0.01% | 191 |
|
|
2015
Q3 | – | Sell |
-39,734
| Closed | -$7.18M | – | 696 |
|
|
2015
Q2 | $7.18M | Buy |
+39,734
| New | +$7.18M | 0.07% | 61 |
|